INmune Bio, Inc. (INMB)

1.43 +0.10 (+7.52%) USD  |  NASDAQ  |  Apr 30, 16:00
1.43 0.00 (0.00%) After-Hours: 16:44
More

INmune Bio EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for INMB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
AngioDynamics, Inc. Upgrade
Omeros Corp. Upgrade
Precipio, Inc. Upgrade
PDS Biotechnology Corp. Upgrade
Sangamo Therapeutics, Inc. Upgrade